These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 30062606

  • 1. Performance of 111In-labelled PSMA ligand in patients with nodal metastatic prostate cancer: correlation between tracer uptake and histopathology from lymphadenectomy.
    Mix M, Reichel K, Stoykow C, Bartholomä M, Drendel V, Gourni E, Wetterauer U, Schultze-Seemann W, Meyer PT, Jilg CA.
    Eur J Nucl Med Mol Imaging; 2018 Nov; 45(12):2062-2070. PubMed ID: 30062606
    [Abstract] [Full Text] [Related]

  • 2. 99mTc-labelled PSMA ligand for radio-guided surgery in nodal metastatic prostate cancer: proof of principle.
    Mix M, Schultze-Seemann W, von Büren M, Sigle A, Omrane MA, Grabbert MT, Werner M, Gratzke C, Meyer PT, Jilg CA.
    EJNMMI Res; 2021 Mar 04; 11(1):22. PubMed ID: 33661414
    [Abstract] [Full Text] [Related]

  • 3. Diagnostic Accuracy of Ga-68-HBED-CC-PSMA-Ligand-PET/CT before Salvage Lymph Node Dissection for Recurrent Prostate Cancer.
    Jilg CA, Drendel V, Rischke HC, Beck T, Vach W, Schaal K, Wetterauer U, Schultze-Seemann W, Meyer PT.
    Theranostics; 2017 Mar 04; 7(6):1770-1780. PubMed ID: 28529650
    [Abstract] [Full Text] [Related]

  • 4. Results from extended lymphadenectomies with [111In]PSMA-617 for intraoperative detection of PSMA-PET/CT-positive nodal metastatic prostate cancer.
    Jilg CA, Reichel K, Stoykow C, Rischke HC, Bartholomä M, Drendel V, von Büren M, Schultze-Seemann W, Meyer PT, Mix M.
    EJNMMI Res; 2020 Mar 06; 10(1):17. PubMed ID: 32144598
    [Abstract] [Full Text] [Related]

  • 5. Prospective evaluation of 68Gallium-prostate-specific membrane antigen positron emission tomography/computed tomography for preoperative lymph node staging in prostate cancer.
    van Leeuwen PJ, Emmett L, Ho B, Delprado W, Ting F, Nguyen Q, Stricker PD.
    BJU Int; 2017 Feb 06; 119(2):209-215. PubMed ID: 27207581
    [Abstract] [Full Text] [Related]

  • 6. Value of 111 In-prostate-specific membrane antigen (PSMA)-radioguided surgery for salvage lymphadenectomy in recurrent prostate cancer: correlation with histopathology and clinical follow-up.
    Rauscher I, Düwel C, Wirtz M, Schottelius M, Wester HJ, Schwamborn K, Haller B, Schwaiger M, Gschwend JE, Eiber M, Maurer T.
    BJU Int; 2017 Jul 06; 120(1):40-47. PubMed ID: 27862863
    [Abstract] [Full Text] [Related]

  • 7. Detection Rate of 18F-Choline PET/CT and 68Ga-PSMA-HBED-CC PET/CT for Prostate Cancer Lymph Node Metastases with Direct Link from PET to Histopathology: Dependence on the Size of Tumor Deposits in Lymph Nodes.
    Jilg CA, Drendel V, Rischke HC, Beck TI, Reichel K, Krönig M, Wetterauer U, Schultze-Seemann W, Meyer PT, Vach W.
    J Nucl Med; 2019 Jul 06; 60(7):971-977. PubMed ID: 30683768
    [Abstract] [Full Text] [Related]

  • 8. 68Ga-PSMA Positron Emission Tomography/Computed Tomography Provides Accurate Staging of Lymph Node Regions Prior to Lymph Node Dissection in Patients with Prostate Cancer.
    Herlemann A, Wenter V, Kretschmer A, Thierfelder KM, Bartenstein P, Faber C, Gildehaus FJ, Stief CG, Gratzke C, Fendler WP.
    Eur Urol; 2016 Oct 06; 70(4):553-557. PubMed ID: 26810345
    [Abstract] [Full Text] [Related]

  • 9. Robot-Assisted Prostate-Specific Membrane Antigen-Radioguided Surgery in Primary Diagnosed Prostate Cancer.
    Gondoputro W, Scheltema MJ, Blazevski A, Doan P, Thompson JE, Amin A, Geboers B, Agrawal S, Siriwardana A, Van Leeuwen PJ, van Oosterom MN, Van Leeuwen FWB, Emmett L, Stricker PD.
    J Nucl Med; 2022 Nov 06; 63(11):1659-1664. PubMed ID: 35241483
    [Abstract] [Full Text] [Related]

  • 10. 99mTc-PSMA targeted robot-assisted radioguided surgery during radical prostatectomy and extended lymph node dissection of prostate cancer patients.
    Yılmaz B, Şahin S, Ergül N, Çolakoğlu Y, Baytekin HF, Sökmen D, Tuğcu V, Taşçı Aİ, Çermik TF.
    Ann Nucl Med; 2022 Jul 06; 36(7):597-609. PubMed ID: 35426599
    [Abstract] [Full Text] [Related]

  • 11. Prostate-Specific Membrane Antigen-Targeted Radioguided Pelvic Lymph Node Dissection in Newly Diagnosed Prostate Cancer Patients with a Suspicion of Locoregional Lymph Node Metastases: The DETECT Trial.
    Schilham MGM, Somford DM, Küsters-Vandevelde HVN, Hermsen R, van Basten JPA, Hoekstra RJ, Scheenen TWJ, Gotthardt M, Sedelaar JPM, Rijpkema M.
    J Nucl Med; 2024 Mar 01; 65(3):423-429. PubMed ID: 38176721
    [Abstract] [Full Text] [Related]

  • 12. Diagnostic Accuracy of 64Copper Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography for Primary Lymph Node Staging of Intermediate- to High-risk Prostate Cancer: Our Preliminary Experience.
    Cantiello F, Gangemi V, Cascini GL, Calabria F, Moschini M, Ferro M, Musi G, Butticè S, Salonia A, Briganti A, Damiano R.
    Urology; 2017 Aug 01; 106():139-145. PubMed ID: 28438628
    [Abstract] [Full Text] [Related]

  • 13. Prostate-specific membrane antigen-radioguided surgery for metastatic lymph nodes in prostate cancer.
    Maurer T, Weirich G, Schottelius M, Weineisen M, Frisch B, Okur A, Kübler H, Thalgott M, Navab N, Schwaiger M, Wester HJ, Gschwend JE, Eiber M.
    Eur Urol; 2015 Sep 01; 68(3):530-4. PubMed ID: 25957851
    [Abstract] [Full Text] [Related]

  • 14. Prostate-specific membrane antigen-guided salvage lymph node dissection in recurrent prostate cancer: a novel technology to detect lymph node metastases.
    Maurer T, Gschwend JE, Eiber M.
    Curr Opin Urol; 2018 Mar 01; 28(2):191-196. PubMed ID: 29028767
    [Abstract] [Full Text] [Related]

  • 15. Pelvic lymph node dissection for nodal oligometastatic prostate cancer detected by 68Ga-PSMA-positron emission tomography/computerized tomography.
    Hijazi S, Meller B, Leitsmann C, Strauss A, Meller J, Ritter CO, Lotz J, Schildhaus HU, Trojan L, Sahlmann CO.
    Prostate; 2015 Dec 01; 75(16):1934-40. PubMed ID: 26356236
    [Abstract] [Full Text] [Related]

  • 16. [18F]-Fluciclovine PET/CT for preoperative nodal staging in high-risk primary prostate cancer: final results of a prospective trial.
    Zanoni L, Bianchi L, Nanni C, Pultrone C, Giunchi F, Bossert I, Matti A, Schiavina R, Fiorentino M, Romagnoli D, Fonti C, Lodi F, D'Errico A, Brunocilla E, Porreca A, Fanti S.
    Eur J Nucl Med Mol Imaging; 2021 Dec 01; 49(1):390-409. PubMed ID: 34213609
    [Abstract] [Full Text] [Related]

  • 17. 11C-choline positron emission tomography/computerized tomography for preoperative lymph-node staging in intermediate-risk and high-risk prostate cancer: comparison with clinical staging nomograms.
    Schiavina R, Scattoni V, Castellucci P, Picchio M, Corti B, Briganti A, Franceschelli A, Sanguedolce F, Bertaccini A, Farsad M, Giovacchini G, Fanti S, Grigioni WF, Fazio F, Montorsi F, Rigatti P, Martorana G.
    Eur Urol; 2008 Aug 01; 54(2):392-401. PubMed ID: 18456393
    [Abstract] [Full Text] [Related]

  • 18. Is 11C-choline Positron Emission Tomography/Computed Tomography Accurate to Detect Nodal Relapses of Prostate Cancer After Biochemical Recurrence? A Multicentric Study Based on Pathologic Confirmation from Salvage Lymphadenectomy.
    Oderda M, Joniau S, Palazzetti A, Falcone M, Melloni G, Van Den Bossche H, Deconinck S, Zattoni F, Karnes RJ, Gontero P.
    Eur Urol Focus; 2018 Mar 01; 4(2):288-293. PubMed ID: 30205893
    [Abstract] [Full Text] [Related]

  • 19. Initial multicentre experience of 68 gallium-PSMA PET/CT guided robot-assisted salvage lymphadenectomy: acceptable safety profile but oncological benefit appears limited.
    Siriwardana A, Thompson J, van Leeuwen PJ, Doig S, Kalsbeek A, Emmett L, Delprado W, Wong D, Samaratunga H, Haynes AM, Coughlin G, Stricker P.
    BJU Int; 2017 Nov 01; 120(5):673-681. PubMed ID: 28548372
    [Abstract] [Full Text] [Related]

  • 20. Topography of lymph node metastases in prostate cancer patients undergoing radical prostatectomy and extended lymphadenectomy: results of a combined molecular and histopathologic mapping study.
    Heck MM, Retz M, Bandur M, Souchay M, Vitzthum E, Weirich G, Mollenhauer M, Schuster T, Autenrieth M, Kübler H, Maurer T, Thalgott M, Herkommer K, Gschwend JE, Nawroth R.
    Eur Urol; 2014 Aug 01; 66(2):222-9. PubMed ID: 23465520
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.